Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-07-23Clinical Trial Update: Clinical Trial on Diabetes Expert Patients Programme [NA]
This update concerns a clinical trial evaluating a Diabetes Expert Patients Programme for Type 2 diabetes. No trial results or current statu…
-
FDA approval · 2013-07-22FDA Approved: PIOGLITAZONE AND GLIMEPIRIDE — Supplemental Application (Prasco Laboratories)
FDA approves a supplemental application from Prasco Laboratories for a pioglitazone and glimepiride fixed-dose combination product. This all…
-
CLINICAL_TRIALS trial_result · 2013-07-19Clinical Trial Update: An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial evaluating CKD-501 as monotherapy for glycemic control in adults with type 2 diabetes mellitus. The study has completed.
-
FDA approval · 2013-07-19FDA Approved: JANUMET XR — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUMET XR (sitagliptin and metformin hydrochloride) from Merck Sharp & Dohme LLC.
-
FDA approval · 2013-07-19FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' metformin hydrochloride as an original-generic drug application.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-19Clinical Trial Update: Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks, in Drug naïve or Previously Treated Type 2 Diabetic Patients With Insufficient Glycaemic Control [Phase 3]
This Phase 3 trial evaluated linagliptin 5 mg once daily for 24 weeks in adults with Type 2 diabetes (drug-naïve or previously treated) with…
-
CLINICAL_TRIALS trial_result · 2013-07-19Clinical Trial Update: A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide [Phase 1]
Phase 1 study assessing safety and pharmacokinetics/pharmacodynamics of sustained-release exenatide in people with Type 2 diabetes mellitus.
-
EMA withdrawal · 2013-07-18EMA Withdrawn: Sepioglin (pioglitazone hydrochloride) — Vaia S.A.
Europen EMA withdrawn status for Sepioglin (pioglitazone hydrochloride) by Vaia S.A., originally for type 2 diabetes, with withdrawal decisi…
-
FDA approval · 2013-07-18FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for LANTUS SOLOSTAR (insulin glargine) from Sanofi-aventis U.S. LLC.
-
FDA approval · 2013-07-18FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Clinical Verification of Peptide Biomarkers for Type 2 Diabetes Mellitus
Completed clinical trial evaluating peptide biomarkers for Type 2 diabetes mellitus conducted under sponsorship of the Beijing Institute of …
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: A Randomized Trial to Assess the Efficacy and Safety of GO2KA1(Chitosan Oligosaccharide)on Blood Glucose Control [Phase 2, Phase 3]
Completed randomized Phase 2/3 trial evaluating GO2KA1 (chitosan oligosaccharide) for blood glucose control in adults with impaired fasting …
-
CLINICAL_TRIALS research · 2013-07-17Clinical Trial Update: Periodontal Treatment and Glycemic Control [NA]
This document provides an update on a clinical trial examining whether periodontal treatment can improve glycemic control in adults with Typ…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: TeamCare PCN: Collaborative Care for Diabetes and Depression [NA]
The TeamCare PCN study evaluating collaborative care for patients with type 2 diabetes and depression has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Healthy Eating & Active Living for Diabetes in Primary Care Networks [NA]
The clinical trial evaluating a healthy eating and active living program for adults with type 2 diabetes in primary care networks has comple…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Dietary Effects on Circulating Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Activity and Enzyme Activity in Peripheral Blood Mononuclear Cells (PBMCs) in Patients With Prediabetes or Newly Diagnosed Type 2 Diabetes [NA]
This completed clinical trial studied how dietary changes influence circulating Lp-PLA2 activity and enzyme activity in peripheral blood mon…
-
CLINICAL_TRIALS research · 2013-07-10Clinical Trial Update: Triple Therapy in Type 2 Diabetic Patients [Phase 4]
This clinical trial update notes a Phase 4 study evaluating a triple therapy regimen in patients with Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2013-07-09Clinical Trial Update: MK-0431/ONO-5435 Phase III Clinical Trial-Rapid-acting Insulin Secretagogue Add-on Study in Patients With Type 2 Diabetes [Phase 3]
This update notes the completion of a Phase III trial evaluating MK-0431/ONO-5435 as a rapid-acting insulin secretagogue add-on therapy for …
-
CLINICAL_TRIALS trial_result · 2013-07-08Clinical Trial Update: Evaluation of the Effectiveness and Safety of Physician Versus Patient-led of Insulin Glargine Initiation and Titration in Type 2 Diabetes Mellitus [Phase 4]
A Phase 4 study comparing physician-led versus patient-led initiation and titration of insulin glargine in adults with Type 2 diabetes, eval…
-
CLINICAL_TRIALS trial_result · 2013-07-08Clinical Trial Update: Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222) [Phase 1]
A Phase 1 study by Merck evaluated the glucoregulatory effects of a GLP-1 receptor activator (MK-0000-222) in adults with Type 2 Diabetes Me…
-
CLINICAL_TRIALS trial_result · 2013-07-08Clinical Trial Update: Free Fatty Acids and Vascular Function in Subjects With Diabetes [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigated free fatty acids and vascular function in subjects with type 2 diabetes; results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-07-08Clinical Trial Update: Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM) [Phase 4]
Phase 4 clinical trial comparing insulin glargine/insulin glulisine regimen to insulin aspart/insulin aspart protamine 30/70 in patients wit…
-
CLINICAL_TRIALS research · 2013-07-08Clinical Trial Update: The Effect of Intensive Multifactorial Therapy on Endothelial Function in Newly Diagnosed Type 2 Diabetes [Phase 2]
A Phase 2 clinical trial update examining the impact of intensive multifactorial therapy on endothelial function in newly diagnosed type 2 d…
-
CLINICAL_TRIALS withdrawal · 2013-07-02Clinical Trial Update: A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes [Phase 4]
A Phase 4 long-term trial comparing liraglutide to glimepiride, both added to metformin, in patients with Type 2 Diabetes has been withdrawn…
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: Pilot Study to Assess Pre-packaged, Portion-controlled Meal Plan on Weight Loss [NA]
A completed pilot study evaluated a pre-packaged, portion-controlled meal plan for weight loss in individuals with Type 2 Diabetes.